In light of recent concerns surrounding potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, the ...
Pfizer beat first-quarter profit estimates on Wednesday, benefiting from cost cuts and strong sales for its pneumonia and ...
Investor's Business Daily on MSN10h
Pfizer Jumps On 'Massive' First-Quarter Upside Thanks To Paxlovid SurprisePfizer stock jumped early Wednesday after the Big Pharma behemoth reported adjusted earnings of 82 cents per share on $14.88 billion in first-quarter sales.Please watch the video at Investors.com - ...
Pfizer bumped up its earnings guidance on Wednesday while reporting better financial results than expected as it works to ...
Following the lead of Eli Lilly, Pfizer will establish a ... The Prevnar family of vaccines to prevent pneumococcal disease ...
The EU's drug watchdog urged that anti-COVID-19 jabs be updated before another round of vaccinations to counter a new variant ...
A major bivalent COVID-19 vaccine induces production of neutralizing antibodies against the coronavirus that circulated at the start of the pandemic as well as subvariants of omicron, albeit less ...
GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback